Although this was discovered due to the presence on HDL of PON1 and its contribution to the anti-oxidative capacity of HDL, the lactonase activity of PON1 may also contribute to the mechanism by which it reduces ASCVD risk. This evidence concerns the gene PON1 and atherosclerosis.